Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.62 |
| ▸ | NPY1R | P25929 | 7/20 | 0.62 |
| ▸ | NPY2R | P49146 | 5/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.53 |
| ▸ | TFPI | P10646 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29794248 | 0.93 | NPY4R (0.56) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL29805234 | 0.92 | QRFPR (0.58) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL30820017 | 0.91 | NPY4R (0.63) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL29794245 | 0.91 | NPY4R (0.58) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL38660704 | 0.90 | NPY5R (0.58) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL29805279 | 0.89 | QRFPR (0.60) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL29805232 | 0.89 | QRFPR (0.60) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL31261768 | 0.88 | NPY4R (0.57) | NPY4RNPY5RNPY1RNPY2RTFPI | |
| SCHEMBL29670861 | 0.88 | QRFPR (0.54) | NPY4RNPY5RNPY1RNPY2ROPRD1 | |
| SCHEMBL29679886 | 0.88 | NPY5R (0.56) | NPY4RNPY5RNPY1RNPY2ROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12227563-B2 | Anti-IGF-I receptor humanized antibody | TEIJIN PHARMA LIMITED (JP) | 2025-02-18 | — | — | US | disclosed |
| CN-110691794-B | anti-IGF-I receptor antibodies | 帝人制药株式会社 | 2023-10-27 | — | — | CN | disclosed |
| US-20230192868-A1 | ANTI-IGF-I RECEPTOR ANTIBODY | TEIJIN PHARMA LIMITED (JP) | 2023-06-22 | — | — | US | disclosed |
| US-11629194-B2 | Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies | TEIJIN PHARMA LIMITED (JP) | 2023-04-18 | — | — | US | disclosed |
| US-20220033485-A1 | ANTI-IGF-I RECEPTOR HUMANIZED ANTIBODY | TEIJIN PHARMA LIMITED (JP) | 2022-02-03 | — | — | US | disclosed |